ARCHIVES

FDA Approves Gleevec In 73 Days, A Speed Record.

This article is from The Cancer Letter archive.

Vol. 27 No. 20 | May 18, 2001

Download PDF Visit The Full Archive

Related Articles

PDQ Used Mainly For Information To Public, Not Much By Non-Oncologists, Evaluation Finds

August 18, 1989

ACS President & COO Resigns Unexpectedly; Was Seen as Contender for CEO Position

December 19, 2014

Gerstner Resigns From NA, MSK Board After Taking RJR Job

March 24, 1989

FDA Approves Ixempra For Metastatic Breast Cancer Resistant To Other Therapy

October 26, 2007

Dial Access Offers Caner Consultation Services

February 21, 1975

Phase III Study Evaluating Halaven Fails To Meet Primary Endpoints

July 27, 2012